Business Description
Pharming Group N.V. is a Dutch pharmaceutical company founded in 1988 and based in Leiden, the Netherlands, that focuses on developing treatments for rare and serious medical conditions. Its two main products are RUCONEST, used to treat sudden attacks in patients with a rare swelling disorder called hereditary angioedema, and Joenja, a pill designed to treat a rare immune system condition known as activated PI3K delta syndrome. The company sells its products across the United States, Europe, and other markets worldwide, and works alongside Novartis through a licensing and development partnership.
